Evidence map›Paper›PMID 36609385›Full record

ArticleChild and adolescent psychiatry and mental health2023

Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain.

Xingguang Luo, Xiandong Lin, Jaime S Ide, Xinqun Luo, Yong Zhang, Jianying Xu, Leilei Wang, Yu Chen, Wenhong Cheng, Jianming Zheng and 8 more

Open access · goldAbstract read
In one paragraph

Article in Child and adolescent psychiatry and mental health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 2 countries.

Xingguang Luo *Beijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Xiandong Lin *Laboratory of Radiation Oncology and Radiobiology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, 350014, China.
Jaime S IdeDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
Xinqun LuoDepartment of Neurosurgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China.
Yong ZhangTianjin Mental Health Center, Tianjin, 300222, China.
Jianying XuZhuhai Center for Maternal and Child Health Care, Zhuhai, 519000, Guangdong, China.
Leilei WangBeijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Yu ChenDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
Wenhong ChengShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China.
Jianming ZhengNational Medical Center for Infectious Diseases, Huashan Hospital, Fudan University School of Medicine, Shanghai, 200030, China.
Zhiren WangBeijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Ting YuBeijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Reyisha TaximaimaitiDepartment of Neurology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Xiaozhong JingDepartment of Neurology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Xiaoping WangDepartment of Neurology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Yuping CaoDepartment of Psychiatry, Second Xiangya Hospital, Central South University; China National Clinical Research Center On Mental Disorders, China National Technology Institute On Mental Disorders, Changsha, 410011, Hunan, China. caoyp001@csu.edu.cn.
Yunlong TanBeijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Chiang-Shan R LiDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
Yale University · USBeijing HuiLongGuan Hospital · CNPeking University · CNShanghai First People's Hospital · CNCentral South University · CNFujian Provincial Cancer Hospital · CNHuashan Hospital · CNShanghai Jiao Tong University · CNShanghai Mental Health Center · CNTianjin Anding Hospital · CNWeihai Maternal and Child Health Hospital · CN

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
International Multi-Center ADHD Genetics ProjectR01MH062873 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FARAONE, STEPHEN V · 2002 to 2007
$7.2M
Genetic Influences on ADHD in a Finnish Birth CohortR01MH063706 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALLEY, SUSAN L · 2001 to 2005
$3.3M
Longitudinal Family Study of Pediatric Bipolar DisorderR01MH066237 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI WOZNIAK, JANET · 2003 to 2007
$2.9M
Etiologies of Stimulant Misuse in College StudentsK24DA016264 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WILENS, TIMOTHY E · 2004 to 2013
$1.7M
Genetics of EEG Patterns in ADHDR01NS054124 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, SANDRA K · 2006 to 2010
$1.7M
COLLABORATIVE ADHD GENETICS CONFERENCER13MH059126 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FARAONE, STEPHEN V · 1999 to 2014
$957k
2/5-The Psychiatric GWAS Consortium: Integrated & Coordinated GWAS Meta-AnalysesU01MH085518 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FARAONE, STEPHEN V · 2008 to 2008
$855k
RESPONSE VARIABILITY IN STIMULANT TREATMENT OF ADHDK23MH001966 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCGOUGH, JAMES JOHN · 2000 to 2004
$713k
Drug Response in Pediatric PsychopharmacologyK24MH001805 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCCRACKEN, JAMES T. · 2001 to 2005
$662k
DEVELOPMENTAL SUBTYPES OF JUVENILE BIPOLAR DISORDERK08MH001503 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI WOZNIAK, JANET · 1997 to 2001
$312k
Analysis of an ADHD Whole Genome Association ScanR01MH081803 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FARAONE, STEPHEN V · 2007 to 2007
$157k
NCATS NIH HHS UL1 TR001863NIDA NIH HHS K24 DA016264NIMH NIH HHS K08 MH001503NIMH NIH HHS K23 MH001966NIMH NIH HHS K24 MH001805NIMH NIH HHS R01 MH062873NIMH NIH HHS R01 MH063706NIMH NIH HHS R01 MH066237NIMH NIH HHS R01 MH081803NIMH NIH HHS R13 MH059126NIMH NIH HHS U01 MH085518NINDS NIH HHS R01 NS054124
6 · The paper itself

Abstract

Attention deficit hyperactivity disorder (ADHD) is associated with reduction of cortical and subcortical gray matter volumes (GMVs). The kinectin 1 gene (KTN1) has recently been reported to significantly regulate GMVs and ADHD risk. In this study, we aimed to identify sex-specific, replicable risk KTN1 alleles for ADHD and to explore their regulatory effects on mRNA expression and cortical and subcortical GMVs. We examined a total of 1020 KTN1 SNPs in one discovery sample (ABCD cohort: 5573 males and 5082 females) and three independent replication European samples (Samples #1 and #2 each with 802/122 and 472/141 male/female offspring with ADHD; and Sample #3 with 14,154/4945 ADHD and 17,948/16,246 healthy males/females) to identify replicable associations within each sex. We examined the regulatory effects of ADHD-risk alleles on the KTN1 mRNA expression in two European brain cohorts (n = 348), total intracranial volume (TIV) in 46 European cohorts (n = 18,713) and the ABCD cohort, as well as the GMVs of seven subcortical structures in 50 European cohorts (n = 38,258) and of 118 cortical and subcortical regions in the ABCD cohort. We found that four KTN1 variants significantly regulated the risk of ADHD with the same direction of effect in males across discovery and replication samples (0.003 ≤ p ≤ 0.041), but none in females. All four ADHD-risk alleles significantly decreased KTN1 mRNA expression in all brain regions examined (1.2 × 10

Indexed as

ABCDADHDBasal gangliaCortexGray matter volume (GMV)KTN1

Identifiers

PMID36609385
PMCPMC9824933
OpenAlexW4313597757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.